134 related articles for article (PubMed ID: 37527782)
1. A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active Cancer.
Cohen AT; Wallenhorst C; Choudhuri S; Nassar A; Pollock KG; Martinez C
Thromb Haemost; 2024 Apr; 124(4):324-336. PubMed ID: 37527782
[TBL] [Abstract][Full Text] [Related]
2. Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients.
Martinez C; Katholing A; Wallenhorst C; Cohen AT
Br J Haematol; 2020 May; 189(3):524-533. PubMed ID: 31997309
[TBL] [Abstract][Full Text] [Related]
3. Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States.
Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
J Manag Care Spec Pharm; 2015 Oct; 21(10):965-72. PubMed ID: 26402395
[TBL] [Abstract][Full Text] [Related]
4. Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism.
Ferrazzini E; Méan M; Stalder O; Limacher A; Rodondi N; Aujesky D
Blood Adv; 2023 Jan; 7(2):205-213. PubMed ID: 35381071
[TBL] [Abstract][Full Text] [Related]
5. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes.
Shaw JR; Douketis J; Le Gal G; Carrier M
J Thromb Haemost; 2019 Jul; 17(7):1171-1178. PubMed ID: 31038838
[TBL] [Abstract][Full Text] [Related]
6. Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment.
McBane Ii RD; Vlazny DT; Houghton D; Casanegra AI; Froehling D; Daniels P; Riaz IB; Hodge DO; Wysokinski WE
Thromb Haemost; 2023 May; 123(5):535-544. PubMed ID: 36574777
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
[TBL] [Abstract][Full Text] [Related]
8. Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosis.
Brown C; Brandt W; Wang TF; Delluc A; Carrier M
Thromb Res; 2023 Aug; 228():81-84. PubMed ID: 37301116
[TBL] [Abstract][Full Text] [Related]
9. Bleeding complications in patients on new oral anticoagulants for venous thromboembolism in Kenya.
Obayo A; Ngunga M; Shah J; Sokwala A; Barasa A
Cardiovasc J Afr; 2022 Jul-Aug 23; 33(4):186-192. PubMed ID: 35118489
[TBL] [Abstract][Full Text] [Related]
10. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
[TBL] [Abstract][Full Text] [Related]
11. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
12. Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study.
Riva N; Bellesini M; Di Minno MN; Mumoli N; Pomero F; Franchini M; Fantoni C; Lupoli R; Brondi B; Borretta V; Bonfanti C; Ageno W; Dentali F
Thromb Haemost; 2014 Sep; 112(3):511-21. PubMed ID: 24899092
[TBL] [Abstract][Full Text] [Related]
13. Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment.
Brown JD; Goodin AJ; Lip GYH; Adams VR
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514808
[TBL] [Abstract][Full Text] [Related]
14. Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer-Associated Venous Thromboembolism.
Ullah F; Song J; Rojas Hernandez CM; Kroll MH; Escalante CP; Toale KM
Oncologist; 2023 Nov; 28(11):e1005-e1016. PubMed ID: 37310796
[TBL] [Abstract][Full Text] [Related]
15. Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolism.
Wysokinski WE; Houghton DE; Vlazny DT; Ashrani AA; Froehling DA; Kamath PS; Meverden RA; Hodge DO; Peterson LG; Lang TR; McBane RD; Casanegra AI
Thromb Res; 2023 Jan; 221():37-44. PubMed ID: 36463701
[TBL] [Abstract][Full Text] [Related]
16. DOAC compared to LMWH in the treatment of cancer related-venous thromboembolism: a systematic review and meta-analysis.
Mai V; Tanguay VF; Guay CA; Bertoletti L; Magnan S; Turgeon AF; Lacasse Y; Lega JC; Provencher S
J Thromb Thrombolysis; 2020 Oct; 50(3):661-667. PubMed ID: 32052314
[TBL] [Abstract][Full Text] [Related]
17. Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
Di Nisio M; Raskob G; Büller HR; Grosso MA; Zhang G; Winters SM; Cohen A
Thromb Haemost; 2017 Apr; 117(4):784-793. PubMed ID: 28151543
[TBL] [Abstract][Full Text] [Related]
18. External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism.
Klok FA; Barco S; Konstantinides SV
Thromb Haemost; 2017 Jun; 117(6):1164-1170. PubMed ID: 28276566
[TBL] [Abstract][Full Text] [Related]
19. Factor Xa Inhibition for the Treatment of Venous Thromboembolism Associated With Cancer: A Meta-Analysis of the Randomised Controlled Trials.
Murphy AC; Koshy AN; Farouque O; Yeo B; Raman J; Kearney L; Yudi MB
Heart Lung Circ; 2022 May; 31(5):716-725. PubMed ID: 34896013
[TBL] [Abstract][Full Text] [Related]
20. Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register.
Palareti G; Legnani C; Antonucci E; Cosmi B; Falanga A; Poli D; Mastroiacovo D; Pengo V; Ageno W; Testa S
Ther Adv Drug Saf; 2021; 12():20420986211062965. PubMed ID: 34987749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
